Cooperations Neuland Laboratories Shake Hands with API
Neuland Laboratories has announced a manufacturing collaboration with Tokyo- based API (APIC), a healthcare unit of Mitsubishi Chemical Holdings Group that produces APIs, intermediates and investigational new drugs, along with fine chemicals and reagents.
Hyderabad/India – Under the terms of the agreement, API Corporation is making an investment in Neuland’s facilities that will provide APIC with dedicated capacity for meeting the needs of its customers. The facilities will be operated by Neuland employees and the two companies will share oversight and management responsibilities.
“We are impressed with Neuland’s long history of quality production and regulatory excellence. In addition, their business model of being solely focused on API and intermediates manufacture makes them an ideal partner for APIC,” said Taiichi Emura, President of APIC.